This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivetta, E.
Right arrow Articles by Federico, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivetta, E.
Right arrow Articles by Federico, M.

 Previous Article  |  Next Article 

Journal of Virology, January 2000, p. 483-492, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

cis Expression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails

Eleonora Olivetta,1 Katherina Pugliese,1 Roberta Bona,1 Paola D'Aloja,1 Flavia Ferrantelli,1 Anna Claudia Santarcangelo,1 Gianfranco Mattia,2 Paola Verani,1 and Maurizio Federico1,*

Laboratory of Virology1 and Laboratory of Clinical Biochemistry,2 Istituto Superiore di Sanità, Rome, Italy

Received 12 March 1999/Accepted 10 September 1999

F12 human immunodeficiency virus type 1 (HIV-1) nef is a naturally occurring nef mutant cloned from the provirus of a nonproductive, nondefective, and interfering HIV-1 variant (F12-HIV). We have already shown that cells stably transfected with a vector expressing the F12-HIV nef allele do not downregulate CD4 receptors and, more peculiarly, become resistant to the replication of wild type (wt) HIV. In order to investigate the mechanism of action of such an HIV inhibition, the F12-HIV nef gene was expressed in the context of the NL4-3 HIV-1 infectious molecular clone by replacing the wt nef gene (NL4-3/chi). Through this experimental approach we established the following. First, NL4-3/chi and nef-defective (Delta nef) NL4-3 viral particles behave very similarly in terms of viral entry and HIV protein production during the first replicative cycle. Second, no viral particles were produced from cells infected with NL4-3/chi virions, whatever the multiplicity of infection used. The viral inhibition apparently occurs at level of viral assembling and/or release. Third, this block could not be relieved by in-trans expression of wt nef. Finally, NL4-3/chi reverts to a producer HIV strain when F12-HIV Nef is deprived of its myristoyl residue. Through a CD4 downregulation competition assay, we demonstrated that F12-HIV Nef protein potently inhibits the CD4 downregulation induced by wt Nef. Moreover, we observed a redistribution of CD4 receptors at the cell margin induced by F12-HIV Nef. These observations strongly suggest that F12-HIV Nef maintains the ability to interact with the intracytoplasmic tail of the CD4 receptor molecule. Remarkably, we distinguished the intracytoplasmic tails of Env gp41 and CD4 as, respectively, viral and cellular targets of the F12-HIV Nef-induced viral retention. For the first time, the inhibition of the viral life cycle by means of in-cis expression of a Nef mutant is here reported. Delineation of the F12-HIV Nef mechanism of action may offer additional approaches to interference with the propagation of HIV infection.

* Corresponding author. Mailing address: Laboratory of Virology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Phone: 39-06-49903248. Fax: 39-06-49387184. E-mail: federico{at}virus1.net.iss.it.

Journal of Virology, January 2000, p. 483-492, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ruggiero, E., Bona, R., Muratori, C., Federico, M. (2008). Virological Consequences of Early Events following Cell-Cell Contact between Human Immunodeficiency Virus Type 1-Infected and Uninfected CD4+ Cells. J. Virol. 82: 7773-7789 [Abstract] [Full Text]  
  • Muratori, C., Sistigu, A., Ruggiero, E., Falchi, M., Bacigalupo, I., Palladino, C., Toschi, E., Federico, M. (2007). Macrophages Transmit Human Immunodeficiency Virus Type 1 Products to CD4-Negative Cells: Involvement of Matrix Metalloproteinase 9. J. Virol. 81: 9078-9087 [Abstract] [Full Text]  
  • Miyagawa, S., Nakatsu, S., Nakagawa, T., Kondo, A., Matsunami, K., Hazama, K., Yamada, J., Tomonaga, K., Miyazawa, T., Shirakura, R. (2005). Prevention of PERV Infections in Pig to Human Xenotransplantation by the RNA Interference Silences Gene. J Biochem 137: 503-508 [Abstract] [Full Text]  
  • Omoto, S., Fujii, Y. R. (2005). Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J. Gen. Virol. 86: 751-755 [Abstract] [Full Text]  
  • Costa, L. J., Zheng, Y.-H., Sabotic, J., Mak, J., Fackler, O. T., Peterlin, B. M. (2004). Nef Binds p6* in GagPol during Replication of Human Immunodeficiency Virus Type 1. J. Virol. 78: 5311-5323 [Abstract] [Full Text]  
  • Day, J. R., Munk, C., Guatelli, J. C. (2004). The Membrane-Proximal Tyrosine-Based Sorting Signal of Human Immunodeficiency Virus Type 1 gp41 Is Required for Optimal Viral Infectivity. J. Virol. 78: 1069-1079 [Abstract] [Full Text]  
  • D'Aloja, P., Santarcangelo, A. C., Arold, S., Baur, A., Federico, M. (2001). Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele. J. Gen. Virol. 82: 2735-2745 [Abstract] [Full Text]  
  • Fackler, O. T., d'Aloja, P., Baur, A. S., Federico, M., Peterlin, B. M. (2001). Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity. J. Virol. 75: 6601-6608 [Abstract] [Full Text]  
  • Lever, A M L (2001). Gene therapy for HIV. Sex. Transm. Infect. 77: 93-96 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»